Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.
Moriyama
H
H
Nagata
M
M
Fujihira
K
K
Yamada
K
K
Chowdhury
S A
SA
Chakrabarty
S
S
Jin
Z
Z
Yasuda
H
H
Ueda
H
H
Yokono
K
K
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004342:Drug Hypersensitivity; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000276:immunology* / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008297:Male; D008875:Middle Aged
D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine